FDA Import Refusal 799-4547892-2/11/1 — Cipla Ltd.
The FDA refused shipment 799-4547892-2/11/1 from Cipla Ltd. (India) on Sep 15, 2021. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 15, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JDB08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75